Accelerating cures for cancer by integrating discoveries in biology with innovative technology

The Mark Foundation for Cancer Research funds groundbreaking science across all cancer types through grants to individual investigators and multi-disciplinary teams, as well as venture investment in early-stage companies. Here’s a snapshot of our portfolio since our founding in 2017.

SINCE 2017

146 Research Grants

Over $125 Million Awarded


          • 23% Basic Research
          • 2% Clinical Research
          • 18% Technology Innovation
          • 10% Therapeutic Discovery
          • 47% Translational Science

          SINCE 2017

          Investments in 6 Companies

          Over $20 Million Invested


                  • 32.3% Diagnostics
                  • 18.1% Cell & Gene Therapy
                  • 19.9% Small Molecule Therapy
                  • 29.8% Biologics

                  latest news


                  The Mark Foundation for Cancer Research Announces 2022 Emerging Leader Awards

                  Read More

                  The Mark Foundation for Cancer Research Announces 2021 ASPIRE Awards

                  Read More

                  GE Healthcare, University of Cambridge and Addenbrooke’s Hospital Announce Research Collaboration

                  Read More

                  The Mark Foundation for Cancer Research and RUNX1 Research Program Announce STRIVE Awardees

                  Read More

                  Cambridge Breast Cancer Treatment Programme to be Rolled out across the UK

                  Read More

                  The Mark Foundation Welcomes the 2021 Momentum Fellows

                  Read More